Diabetes Mellitus and Clinical Outcomes in Carotid Artery Revascularization Using Second-Generation, MicroNet-Covered Stents: Analysis from the PARADIGM Study

Table 1

Clinical characteristics of the study cohorts.

	DM ()	Non-DM ()	value
Male (, %)	30 (73.2)	41 (68.3)	0.60
(years, min-max)	(51-86)	(53-81)	0.08
Symptomatic (, %)	25 (61)	30 (50)	0.27
Acute presentation () (n, %)	8 (19.5)	1 (1.7)	0.003
Prior stroke (, %)	20 (48.8)	21 (35)	0.10
RTh (, %)	1 (2.4)	5 (8.3)	0.22
AF (, %)	4 (9.8)	5 (8.3)	0.81
Contralateral CAS/CEA (, %)	2 (4.9)	10 (16.7)	0.07
CAD (, %)	28 (68.3)	36 (60)	0.40
MI (, %)	17 (41.5)	15 (25)	0.08
h/o CABG or PCI (, %)	19 (46.3)	21 (35)	0.25
Arterial hypertension (, %)	36 (87.8)	54 (90)	0.72

RTh: radiotherapy; AF: atrial fibrillation; CAS: carotid artery stenting; CEA: carotid endarterectomy; CAD: coronary artery disease; CABG: coronary artery bypass grafting; PCI: percutaneous coronary intervention; h/o: history of.